Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria.
Meulewaeter S, Aernout I, Deprez J, Engelen Y, De Velder M, Franceschini L, Breckpot K, Van Calenbergh S, Asselman C, Boucher K, Impens F, De Smedt SC, Verbeke R, Lentacker I.
Meulewaeter S, et al. Among authors: verbeke r.
J Control Release. 2024 May 4;370:379-391. doi: 10.1016/j.jconrel.2024.04.052. Online ahead of print.
J Control Release. 2024.
PMID: 38697317
Free article.